{"id":"https://openalex.org/W2394533033","doi":null,"title":"Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patients.","display_name":"Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patients.","publication_year":2008,"publication_date":"2008-05-01","ids":{"openalex":"https://openalex.org/W2394533033","mag":"2394533033","pmid":"https://pubmed.ncbi.nlm.nih.gov/18589480"},"language":"en","primary_location":{"id":"pmid:18589480","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18589480","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The AIDS reader","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088149344","display_name":"Lynda C. Doward","orcid":"https://orcid.org/0000-0002-6236-469X","observed_orcids":["https://orcid.org/0000-0002-6236-469X"]},"institutions":[{"id":"https://openalex.org/I4210116323","display_name":"Galen Research (United Kingdom)","ror":"https://ror.org/02e9za279","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210116323"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lynda C Doward","raw_affiliation_strings":["Galen Research Ltd, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galen Research Ltd, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210116323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113715360","display_name":"Birgitta Dietz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Birgitta Dietz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068562990","display_name":"Jeanette N Wilburn","orcid":"https://orcid.org/0000-0002-9168-5716","observed_orcids":["https://orcid.org/0000-0002-9168-5716"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeanette Wilburn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005618550","display_name":"Stephen Patrick McKenna","orcid":"https://orcid.org/0000-0003-4238-8333","observed_orcids":["https://orcid.org/0000-0003-4238-8333"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen P McKenna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007675629","display_name":"Menaka Bhor","orcid":"https://orcid.org/0000-0001-7014-4104","observed_orcids":["https://orcid.org/0000-0001-7014-4104"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Menaka Bhor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5010066358","display_name":"Rukmini Rajagopalan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rukmini Rajagopalan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7323,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.80026618,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"18","issue":"5","first_page":"242","last_page":"6, 252"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lipoatrophy","display_name":"lipoatrophy","score":0.9789999723434448},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.9269999861717224},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.9670000076293945},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.968999981880188},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9909999966621399},{"id":"https://openalex.org/keywords/psychosocial-well-being","display_name":"psychosocial well-being","score":0.996999979019165},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8550000190734863}],"concepts":[{"id":"https://openalex.org/C2779546735","wikidata":"https://www.wikidata.org/wiki/Q3500973","display_name":"Lipoatrophy","level":5,"score":0.9443812370300293},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9111600518226624},{"id":"https://openalex.org/C150966472","wikidata":"https://www.wikidata.org/wiki/Q3410145","display_name":"Psychosocial","level":2,"score":0.7292272448539734},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.7026026248931885},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5446150302886963},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5277419686317444},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5231927037239075},{"id":"https://openalex.org/C2780941825","wikidata":"https://www.wikidata.org/wiki/Q1538213","display_name":"Lipodystrophy","level":5,"score":0.4738774001598358},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.34025800228118896},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20257610082626343},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.16475257277488708},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.16432765126228333},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.12243211269378662},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006304","descriptor_name":"Health Status","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D036301","descriptor_name":"Qualitative Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D039682","descriptor_name":"HIV-Associated Lipodystrophy Syndrome","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:18589480","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18589480","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The AIDS reader","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2059836477","https://openalex.org/W7100343811","https://openalex.org/W2163327947","https://openalex.org/W1602708594","https://openalex.org/W7128690393","https://openalex.org/W2408824990","https://openalex.org/W7095759893","https://openalex.org/W1691317843","https://openalex.org/W1973965556","https://openalex.org/W2119499403"],"abstract_inverted_index":{"Lipoatrophy":[0],"is":[1],"a":[2,56],"noteworthy":[3],"adverse":[4],"effect":[5],"of":[6,19,66,68],"antiretroviral":[7,72],"therapy.":[8,73],"A":[9],"2-part":[10],"literature":[11,48],"review":[12,49],"was":[13],"conducted":[14],"to":[15,90],"assess":[16],"the":[17,24,27,35,38,60,75],"impact":[18,58],"lipoatrophy":[20,32,54],"in":[21,80,94],"HIV-infected":[22,69],"persons:":[23],"first":[25],"reviewed":[26,37],"qualitative":[28],"studies":[29,40,82],"that":[30,41,53],"reported":[31],"data,":[33],"and":[34,63,86],"second":[36],"clinical":[39,81],"recorded":[42],"patient-reported":[43,76],"outcome":[44,77],"end":[45],"points.":[46],"This":[47],"provided":[50],"considerable":[51],"evidence":[52],"has":[55],"negative":[57],"on":[59],"psychosocial":[61],"well-being":[62],"health-related":[64],"quality":[65],"life":[67],"persons":[70],"receiving":[71],"However,":[74],"measures":[78],"used":[79],"were":[83],"not":[84],"lipoatrophy-specific":[85],"had":[87],"limited":[88],"ability":[89],"show":[91],"real":[92],"changes":[93],"health":[95],"status":[96],"associated":[97],"with":[98],"lipoatrophy.":[99]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}